Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view).
Shares of Intuitive Surgical are up 0.53% at $400.42. The company is worth $141.46B, number 110 out of 300 on our list.
The 52-week range is $328.57 to $603.88. Today's price is about 26% of the way from the low to the high. Holders are behind 9.8% over twelve months, and down 0.4% across the last three months.
Price is above the 50-day average ($373.72) but below the 200-day ($452.60); RSI is 64, and the last 30 sessions moved at roughly 30% annualized volatility.
Revenue for the quarter ended Jun 2026 was $2.89B, up 18.5% from a year earlier, with $823.20M of net profit (a 28.4% margin).
Buyers are paying 45.9 times trailing earnings, 34% below its five-year average of 69.7. The median for its industry group is 37.6.
21 analysts follow the stock and the average call is "buy". The mean target, $489.95, sits 22.4% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Intuitive Surgical makes the da Vinci robotic surgery systems and earns most of its revenue from instruments and service on installed machines.
What tends to move it. Procedure growth, system placements and new models such as da Vinci 5 are the numbers to follow.
Written by hand by the BeStock desk and revised when a business changes. See how we work. Spot something out of date? Tell us.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | +6.5% | Bullish |
| Price vs 50-day average | +7.1% | Bullish |
| Price vs 200-day average | -11.5% | Bearish |
| 50-day vs 200-day | 50d below 200d | Bearish |
| RSI (14) | 64.3 | Bullish |
| MACD (12,26,9) | 5.41 | Bullish |
| Bollinger band position | 92% | Bullish |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Sep 24, 2026 2:00 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 300 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A row is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 3rd percentile, 5-year average 69.7x
#2445 of 2975 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 15th percentile, 5-year average 9.5x
#4673 of 5302 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 5th percentile, 5-year average 18.0x
#4497 of 5141 stocks by PS (1 = cheapest)
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Who holds it, who is betting against it, and where the big money is moving
Net of large-order buying minus selling, in USD. Over this window: −$60.39M (7 inflow days, 13 outflow days).
$400.42 is the latest print for ISRG, a move of +0.53% against yesterday's close of $398.30. Today's low and high so far: $395.18 and $404.19.
Equity value comes to $141.46B at the current price. By that measure it is number 110 of the 300 names in our coverage.
Buyers pay 45.9 times the last twelve months of profit (EPS $7.87). Averaged over five years the multiple has been 69.7, and today's level ranks in the 3rd percentile of its own history.
The year's floor is $328.57 and the ceiling $603.88. Shares are 33.7% away from that ceiling.
Our data shows no dividend paid by Intuitive Surgical over the trailing twelve months.
Of 21 analysts, 86% say buy, 14% hold and 0% sell. Price targets average $489.95, with the most cautious at $391.00 and the most optimistic at $685.00.
Intuitive Surgical makes the da Vinci robotic surgery systems and earns most of its revenue from instruments and service on installed machines.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.